SCHEMBL6206042

SCHEMBL6206042

COc1ccc(Cc2cc3c(cc2Nc2ccccc2)[N]C(=O)N3)cc1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
TSHR P16473 1/20 0.43
CYP2C19 P33261 1/20 0.43
KMT2A Q03164 3/20 0.39
POLB P06746 2/20 0.39
MEN1 O00255 1/20 0.39
ADORA2A P29274 1/20 0.39
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
LMNA P02545 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
CA2 P00918 1/20 0.38
MAPT P10636 3/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6204133 0.86 FPR1 (0.43) CYP3A4CYP2C9TSHRCYP2C19KMT2A
SCHEMBL6202823 0.85 EGFR (0.42) CYP3A4KMT2AMEN1PDE4BLMNA
SCHEMBL6203101 0.84 NPC1 (0.38) CYP3A4KMT2AMEN1ADORA2ALMNA
SCHEMBL6204913 0.83 EGFR (0.42) CA2MAPTALDH1A1
SCHEMBL6205378 0.82 KMT2A (0.40) CYP3A4TSHRKMT2AMEN1LMNA
SCHEMBL6204330 0.82 CNR1 (0.39) CYP3A4KMT2AMEN1LMNASMN1; SMN2
SCHEMBL6205452 0.80 EGFR (0.36) CYP3A4KMT2AMEN1LMNASMN1; SMN2
SCHEMBL6204891 0.79 MAPT (0.38) KMT2AMEN1SMN1; SMN2MAPTKDM4E
SCHEMBL6202905 0.78 LTA4H (0.41) KMT2AMEN1LMNASMN1; SMN2MAPT
SCHEMBL6205611 0.77 MEN1 (0.38) CYP3A4CYP2C9CYP2C19KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1539708-A1 BENZIMIDAZOLONES AND THEIR USE AS CYTOKINE INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2005-06-15 EP disclosed
WO-2004024699-A1 BENZIMIDAZOLONES AND THEIR USE AS CYTOKINE INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2004-03-25 WO disclosed